Aurinia Pharmaceuticals (AUPH) EBIT (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Aurinia Pharmaceuticals | 2.03 Bn | 1.65 Bn | 71.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.62% |
| Dec 31, 2025 | 11.75% |
| Sep 30, 2025 | 48.11% |
| Jun 30, 2025 | -8.07% |
| Mar 31, 2025 | 1,408.99% |
| Dec 31, 2024 | -114.21% |
| Sep 30, 2024 | 876.47% |
| Jun 30, 2024 | 88.58% |
| Mar 31, 2024 | 55.34% |
| Dec 31, 2023 | -82.46% |
| Sep 30, 2023 | -0.58% |
| Jun 30, 2023 | 45.34% |
| Mar 31, 2023 | -5.28% |
| Dec 31, 2022 | -195.82% |
| Sep 30, 2022 | 73.61% |
| Jun 30, 2022 | 5.00% |
| Mar 31, 2022 | -15.83% |
| Dec 31, 2021 | 35.05% |
| Sep 30, 2021 | -6.83% |
| Jun 30, 2021 | 6.74% |
| Mar 31, 2021 | -527.71% |
| Dec 31, 2020 | 80.97% |
| Sep 30, 2020 | -57.52% |
| Jun 30, 2020 | 0.73% |
| Mar 31, 2020 | 22.33% |
| Dec 31, 2019 | -44.76% |
| Sep 30, 2019 | -40.40% |
| Jun 30, 2019 | -15.12% |
| Mar 31, 2019 | -2.56% |
| Dec 31, 2018 | 19.34% |
| Sep 30, 2018 | -14.13% |
| Jun 30, 2018 | -1.91% |
| Mar 31, 2018 | -364.53% |